TY  - JOUR
AU  - Sevilla, Isabel
AU  - Segura, Angel
AU  - Capdevila, Jaume
AU  - Lopez, Carlos
AU  - Garcia-Carbonero, Rocio
AU  - Grande, Enrique
PY  - 2016
DO  - 10.1186/s12885-016-2901-1
UR  - http://hdl.handle.net/10668/10586
T2  - BMC cancer
AB  - There are clinical situations (CS) in which the use of somatostatin analogs (SSAs) in patients with neuroendocrine tumors (NET) is controversial due to lack of evidence. A Delphi study was conducted to develop common treatment guidelines for these CS,...
LA  - en
PB  - BioMed Central
KW  - Delphi study
KW  - Gastroenteropancreatic NETs
KW  - NET
KW  - Neuroendocrine tumors
KW  - SSA
KW  - Somatostatin analogue
KW  - Antineoplastic Agents
KW  - Disease Management
KW  - Expert Testimony
KW  - Female
KW  - Humans
KW  - Intestinal Neoplasms
KW  - Male
KW  - Neuroendocrine Tumors
KW  - Pancreatic Neoplasms
KW  - Somatostatin
KW  - Stomach Neoplasms
KW  - Surveys and Questionnaires
TI  - Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program.
TY  - research article
VL  - 16
ER  -